cis-platinum Clinical Trials

3 actively recruiting trials

Pipeline

Phase 1: 1Phase 1/2: 2

Top Sponsors

Innovent Biologics (Suzhou) Co. Ltd.1
Fudan University1
Akeso1

Indications

Cancer3
Lung Cancer2
Non-small Cell Lung Cancer Stage IIIB/IV1
Advanced Non-Small Cell Lung Cancer1
Colorectal Adenocarcinoma1

Other3 trials

AK129 Combination Therapy for Advanced Solid Tumors

Phase 1/2

Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation

Phase 1

Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.